Inhibiting the effect of (90)Sr-(90)Y ophthalmic applicators on rat corneal neovascularization induced by sutures.

AIM To investigate a practical technique used to inhibit corneal angiogenesis with a (90)Sr-(90)Y ophthalmic applicator. METHODS A (90)Sr-(90)Y ophthalmic applicator was detected with a radioactive nuclide application treatment healthy protection standard. The applicator used was produced through medical dosimetry research; it had a concave applicator add measured the applicator temperature, serviceable humidity range, applicator appearance status, applicator radiation homogeneity, radioautography, and radiological safety of the original applicator surface. A vessel model was established using newborn rats, with sutures around the corneal limbus. Corneal neovascularization (CNV) were observed with a slit lamp. The new vessel length and response area were measured. RESULTS Low-dose radiation can inhibit CNV after corneal sutures. The absorbed dose of the applicator (0.046 Gy/s) was safe for the treatment of it. The lengths of new vessels and the areas of new vessels were lower than the new born vessel rat group (P<0.01). CONCLUSION The optimal radiation dose emitting from the applicator can be safe and potentially used in humans.

[1]  G. Dusting,et al.  NADPH oxidase 2 plays a role in experimental corneal neovascularization. , 2016, Clinical science.

[2]  S. Indraccolo,et al.  Potential of Induced Metabolic Bioluminescence Imaging to Uncover Metabolic Effects of Antiangiogenic Therapy in Tumors , 2016, Front. Oncol..

[3]  Won Hoon Choi,et al.  Evolving Clinical Cancer Radiotherapy: Concerns Regarding Normal Tissue Protection and Quality Assurance , 2016, Journal of Korean medical science.

[4]  T. Veiga-Parga,et al.  Robo 4 Counteracts Angiogenesis in Herpetic Stromal Keratitis , 2015, PloS one.

[5]  S. Gupta,et al.  Hesperetin ameliorates hyperglycemia induced retinal vasculopathy via anti-angiogenic effects in experimental diabetic rats. , 2012, Vascular pharmacology.

[6]  S. Zhang,et al.  Aquaporin-4 upregulated expression in glioma tissue is a reaction to glioma-associated edema induced by vascular endothelial growth factor. , 2012, Oncology reports.

[7]  A. Fernandez-cruz,et al.  Circulating endothelial progenitor cells are reduced in rat oxygen-induced retinopathy despite a retinal SDF-1/CXCR4 and VEGF proangiogenic response. , 2012, Life sciences.

[8]  J. Szepietowski,et al.  Reduced Number of Circulating Endothelial Progenitor Cells (CD133+/KDR+) in Patients with Plaque Psoriasis , 2012, Dermatology.

[9]  Shu-feng Zhang,et al.  Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats , 2012, Cardiovascular Diabetology.

[10]  D. Ribatti,et al.  HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 , 2012, Proceedings of the National Academy of Sciences.

[11]  Shi-you Zhou,et al.  Minocycline Inhibits Alkali Burn-Induced Corneal Neovascularization in Mice , 2012, PloS one.

[12]  M. Chinol,et al.  Yttrium-90 -- current status, expected availability and applications of a high beta energy emitter. , 2012, Current radiopharmaceuticals.

[13]  D. Radzioch,et al.  Sorafenib in combination with ionizing radiation has a greater anti-tumour activity in a breast cancer model , 2012, Anti-cancer drugs.

[14]  M. Abdi,et al.  Absorbed dose assessment of cardiac and other tissues around the cardiovascular system in brachytherapy with 90Sr/90Y source by Monte Carlo simulation. , 2011, Radiation protection dosimetry.

[15]  C. Belka,et al.  Late and very late catch-up after 90Sr/90Y beta-irradiation for the treatment of coronary in-stent restenosis , 2011, Acute cardiac care.

[16]  Malcolm W R Reed,et al.  A critical analysis of current in vitro and in vivo angiogenesis assays , 2009, International journal of experimental pathology.

[17]  Paul T. Finger,et al.  The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma. , 2014, Brachytherapy.

[18]  S. Szabó,et al.  Novel pharmacologic approaches to the prevention and treatment of ulcerative colitis. , 2013, Current pharmaceutical design.

[19]  이익재,et al.  Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer. , 2012 .